Framler
Signal Feed
WatchlistTrack Record
⌕
LIVE
Framler · © 2026
Engine
MethodologySectorsPatternsCompareAlternativesScreenersGlossaryTrack RecordShort SqueezeTop Rated
Research moat
MoatResearchCase Study: NVDA
Company
InvestorsPressBlogChangelogAPIAboutContact
FEATURED ANALYSISNVDATSLAAAPLAMDMSFTMETA
Framler is a quantitative research platform - not a broker, investment advisor, or fiduciary. Nothing on this site constitutes a recommendation to buy, sell, or hold any security. All model outputs - scores, verdicts, intervals, predictions - are for informational and educational purposes only. Past performance does not guarantee future results. Invest at your own risk. Built on public data - SEC EDGAR, ClinicalTrials.gov, PubMed, Yahoo Finance, Finnhub, FMP.
TRUSTStatusSecurity·LEGALTermsPrivacyDisclaimer
← NTLA FULL ANALYSIS

Intellia Therapeutics (NTLA) Forecast

Healthcare$17.56+1.86%
47mixed
FRAMLER SCORE · /100
Prediction Interval
Score: 47(range: 5–94 at 42% confidence)
Current RegimeRISK ON

Markets are in an expansionary regime. Momentum and growth factors tend to perform well.

What the factors say

BULLISH FACTORS
Sector SpilloverSTRONG
Sector MomentumSTRONG
BEARISH FACTORS
Short InterestPOOR
QualityPOOR
NLP ToneWEAK
View full NTLA analysis — factor breakdown, forward returns, news →
Model-generated forecast based on 13 academic factors. Not investment advice. See methodology for how the Framler score is built.